http://www.alexharris.co.uk/mmr_factsheet.doc
|
|
1
Dyers Buildings London
EC1N 2JT Telephone
0207 430 5555 Fax
0207 430 5500 AndAshley
House, Ashley Road, Altrincham,
Cheshire WA14 2DW Telephone
0161 925 5555 Fax
0161 925 5500 Email:
info@alexharris.co.uk Web
Site: http://www.alexharris.co.uk |
Mumps, Measles and Rubella (MMR) Vaccines
and Measles Rubella (MR) Vaccines
This fact
sheet concentrates on the medical, scientific and ethical issues relating to
the MMR/MR vaccines in the context of possible legal claims. It has been
prepared to help those who believe their children have been damaged by these
vaccines.
Nothing in
this fact sheet should be taken to be medical advice. Vaccination decisions
should be made only after proper consultation with your medical adviser.
The
information in this fact sheet is not now up to date. Investigations have moved
on, and further relevant information has come to light. For additional material
please refer to our web site at www.alexharris.co.uk
The Medicines
Control Agency (the body in charge
of vaccine safety) were invited to comment on the fact sheet. A few minor
corrections have been made in response to their representations. Where there
are two sides to the argument, we have left in our version, and in the
interests of balance have added their views as footnotes.[1]
Introduction
Background: Setting the illnesses in context
The vaccines
Safety and effectiveness of the vaccines
Side effects: the official view
Side effects: our investigations
Conclusion
Introduction
In this fact
sheet we give specific information about the MMR and MR vaccines and their side
effects. Our objective is two-fold. Primarily we have to operate within the
English Legal System, which in this context functions only in terms of
financial compensation. Our aim therefore is to help families whose children
have been affected by the vaccines to obtain proper compensation for their
injuries. We are using law that was introduced into this country in 1988 as a
result of European Community directives. This law (the Consumer Protection Act 1987) imposes strict liability on the
manufacturers of products which are unsafe.
The MMR
vaccine is claimed to cause serious side effects in only one in a million
children. Even if that were the case, the risk to the children who are affected
is not one in a million, but 100%. An American court[2]
has decided that there can be no acceptable level of the incidence of serious
side effects from vaccines, and has stated that compensation should be paid in
any case where it is proved that the side effect was caused by the
vaccine. We would hope that English
courts would adopt the same approach.
Because
vaccines are such an emotive issue, we have gone further and tried to set the
whole subject in context. What follows is an overview of the vaccines, which we
hope will give full information not only to the families we are seeking to help
but also to those (including medical practitioners) who have found it difficult
to obtain detailed information about these childhood diseases and immunization
against them.
We have tried
to keep a balanced view about the benefits and risks of immunisation, but as we
have researched deeper into the issues it has become harder to do so.
We have read and heard many harrowing accounts of the injuries that children (and adults) have suffered after the vaccines have been administered. We have listened to the dismissive comments from representatives of the Government and some members of the medical profession. We are now worried that the safety information about these vaccines may not be entirely accurate.
We are also
seriously concerned that safety monitoring for these vaccines appears to fall
far short of what the public is entitled to expect and we believe that the
information given to parents is certainly lamentably incomplete.
We are
concerned that risks associated with the actual illnesses may have been
exaggerated, perhaps to frighten people into having their children vaccinated.
Some have suggested that we underplay the risks of the illnesses themselves.
There is no doubt that, of the three illnesses (mumps, measles, rubella),
measles should be regarded as the most serious, but we find it difficult to
reconcile the claims now made about the illness: "complications have been
reported in one in 15 notified cases."[3]
with the reassuring statement we quote in the next section: "In the vast
majority of children who catch measles the disease disappears within 10
days" [4], [5]
We have also included references to and quotations from source material. This represents a tiny fraction of the information we hold, which runs to hundreds of papers and thousands of references on MMR and vaccines generally. Feel free to show this fact sheet to your medical advisors. We believe that we can substantiate every statement made in this fact sheet from mainstream medical literature or official sources. Where possible we have given the source material in footnotes. It is quite significant that many of the medical and scientific findings we have researched are not new: the information about the mechanisms, which cause side effects, was available to the medical and scientific community years ago. We will be happy to supply more information either to you or to your doctor.
Background:
Setting the illnesses in context
The "official" perception of the childhood diseases which are the subject of the MMR or MR vaccines (Measles, Mumps, Rubella) has modified over the years – with descriptions of the diseases increasingly emphasising their seriousness.
It is instructive to put the three diseases into perspective. The following extracts and summaries are from two family health guides published 13 years apart:
the
MacMillan Guide to Family Health, an authoritative health manual edited
by Dr. Tony Smith the deputy editor of
the British Medical Journal and published in 1982 [6];
and
the British
Medical Association Complete Family Health Encyclopaedia published in
1995 (first published 1990). This is also edited by Dr. Tony Smith.
We have chosen
the first publication because it came
out some years before MMR vaccines were
introduced into this country. Contrast the entries in the two publications:
From the MacMillan Guide to Family Health 1982:
"Mumps is a common infectious
disease caused by a virus. After an incubation period of 2-4 weeks the salivary
glands swell, the parotid gland (just in front of the ear) is particularly
infected. Swellings are usually accompanied by a raised temperature and a
general feeling of illness. It is probably the most common childhood infectious
disease but not as contagious as measles.
"A fairly common risk of mumps is
the swelling of testes in a boy or the ovaries in a girl. This is much more
common in an adult. Invariably the swelling goes down after a few days leaving
no after effects. It is excessively rare for the swelling to cause sterility. A
rare complication is acute pancreatitis, which passes within a few days.
"Mumps is
generally a mild disease. The usual outcome is complete recovery within about
10 days." [our emphasis]
In contrast From the British Medical Association Complete
Family Health Encyclopaedia 1995:
"Mumps is an acute viral illness mainly of childhood... Serious complications are uncommon. However, in teenage and adult males, mumps can be a highly uncomfortable illness in which one or both testes become inflamed and swollen... Most infections are acquired at school or from infected family members. In the US, where many states require proof of mumps vaccination for school entry, the incidence has dropped markedly over the last 20 years. In the UK by contrast, before routine immunisation was introduced in 1988, mumps affected a large proportion of the population at sometime in their lives, usually between the ages of 5 and 10. An occasional complication of mumps is meningitis... A less common complication of mumps is pancreatitis, which causes abdominal pain and vomiting. In males after puberty, orchitis (inflammation of the testis) develops in about a quarter of the cases. Subsequently the affected testis may shrink to smaller than normal size. In rare cases, mumps orchitis affects both testes leading to infertility."
[The book also contains strong warnings
about the consequences of older people coming into contact with those infected
with mumps.]
Rubella (German Measles)
From the MacMillan Guide to Family Health 1982:
"This is
a very mild infectious disease in the majority of children who catch it, it
causes no more inconvenience than a common cold. The incubation period is 14‑21
days and the first symptoms are a slightly raised temperature, swollen glands
behind the ears and a rash appearing on the first or second day first on the
face and then spreading to the rest of the body. By the fourth or fifth day,
all symptoms have faded away.”
“It is slightly less common than
measles and not as highly contagious so does not occur in epidemics in quite
the same way.”
“Like other childhood infectious
diseases, German measles carries the risk of encephalitis though this occurs in
only one case in 6000. A more common complication, particularly in adults is stiff
swollen joints (infectious arthritis).”
“Because German measles is such a mild
disease, little specific treatment is required but the disease is known to
cause damage to babies developing in the uterus. It is therefore essential to
contact any pregnant woman who has been exposed to German measles."
The British
Medical Association Complete Family Health Encyclopaedia 1995: The book does
not emphasise the seriousness of the illness as much as it does in respect of
measles and mumps but does state that vaccines are long lasting in their
effect.
Measles
From the MacMillan Guide to Family Health 1982:
"Measles
is a highly contagious disease which chiefly affects the skin and respiratory
tract. It is a notifiable disease. The incubation period is 10-14 days. The
first symptoms are raised temperature, runny nose, red watering eyes, dry cough
and sometimes diarrhoea. By the third day the temperature falls and tiny white
spots like grains of salt appear inside the mouth. On the fourth and fifth days
temperature rises again and the characteristic measles rash appears, starting
on the forehead and behind the ears and gradually spreading to the rest of the
body but not usually the limbs. By the sixth day the rash is fading and by the
seventh day all the symptoms have gone.”
"In the vast majority of children who catch
measles the disease disappears within 10 days and the only after effect is
lifelong immunity to another attack"[7]
[our emphasis]
In contrast
1995 from the British Medical Association
Complete Family Health Encyclopaedia 1995:
The following are quotations from the book. Note the difference in emphasis and detail.
"A potentially dangerous viral
illness that causes a characteristic rash and a fever… Measles was once very
common throughout the world occurring in epidemics. It is now less common in
developed countries due to immunisation.”
“Prevention of measles is important
because it can have rare but serious complications.... It can also be serious,
and sometimes fatal, in children with impaired immunity (such as those being
treated for leukaemia and those infected with AIDs virus). In developing
countries measles is still common, accounting for more than one million deaths
every year, especially in malnourished children whose defences against infection
are seriously impaired."
"The most common complications are
ear and chest infections. Diarrhoea vomiting and abdominal pain also occur.
Febrile convulsions are common with measles and are not usually serious. A
serious complication, occurring in about one in a thousand cases is
encephalitis (inflammation of the brain).... Seizures and coma may follow
sometimes leading to mental retardation or even death. Very rarely (in about
one in a million cases) a progressive brain disorder, known as SSPE, develops
years after the acute illness. Measles during pregnancy results in death of the
foetus in about one fifth of the cases."
"Immunisation against measles is
usually offered at about 15 months of age and produces immunity in about 97% of
the cases. Side effects of the measles vaccine are generally mild."
[no mention of any serious side effects
of the vaccine]
Measles viewed in 1967
Another
example of the apparent change in the nature of measles is this extract from a
paper by Christine Miller BM B.Ch, of the National Institute for Medical
Research London published in 1967 one year before the measles vaccine was
introduced on a wide scale.
"MEASLES is now the commonest
infectious disease of childhood in the United Kingdom. It occurs in biennial epidemics in which the
total number of cases usually exceeds half a million, and between these peaks
there is a continuous substantial incidence.
There is no doubt that most of these cases in England today are mild,
last only for a short period, are not followed by complications and are rarely
fatal, but this is not the whole picture and other factors have to be
considered.”
"OPPOSING
VIEWS: Measles is always a social
nuisance whenever it occurs and nearly always an unpleasant episode for the
child and the family. Most children
develop measles during preschool or early school life, and when more than one
child is infected at the same time it is an exhausting and trying period for
the mother, especially if she goes out to work. Outbreaks in schools and hospital wards also cause waste of time
and inconvenience, and there have been severe outbreaks in the Armed
Forces. To the doctor an epidemic of
measles means an increase in work in the late winter and early spring when he is
already especially busy. A recent survey
in a number of areas in this country (unpublished) showed that the majority of
measles cases are visited at least twice by the general practitioner, and in
many cases more than twice. This is a heavy burden on the National Health
Service, which also bears the cost of antibiotics with which most cases are
treated.”
“In spite of these factors, some
physicians consider that measles is so mild a complaint that a major effort at
prevention is not justified. On the
other hand, others believe that, on the whole, the implications of an epidemic
are serious and that the disease should be prevented if possible. These
opposing views are of topical importance in considering what use should be made
of measles vaccines"[8].
Measles viewed in 1979
In the well
respected publication The Theory and
Practice of Public Health [9]
it is stated:
"While the infectivity of measles
is still very high in all types of population and environment, the results of
infection vary greatly. In Britain and many other developed countries today
measles has lost much of its severity, but the disease can still sweep through
virgin populations with great ferocity... On the other hand immunity is
probably lifelong, and when measles has invaded an isolated community, older
members have been protected by immunity acquired over sixty years earlier. In
developing or underdeveloped countries measles may still cause serious
complications and carry a fatality rate of up to 25 per cent."[10]
"Unfortunately, measles can be
much more serious than most people think. School-age children who get it are
likely to be very ill. These
children will have a high temperature, a rash, a cough, a cold and sore eyes.
Other symptoms are headaches and not liking bright light. Measles can cause
pneumonia, blindness, deafness and even brain damage. Measles can also be
fatal. In fact it's the disease most likely to cause inflammation of the brain.
This is known as 'encephalitis'. Worryingly, four out of ten children who get
this kind of encephalitis will suffer long-term brain damage."
Our reason for
emphasising this apparent change in the perception of the illnesses is to raise
a question‑mark over the rationale for MR or MMR vaccines.
Vaccination is
an invasive procedure. Children, once vaccinated, are inevitably put on direct
risk (however large or small that risk might be) of vaccination side effects. On
the other hand, if nature is allowed to take its course, they may never catch
all or any of the illnesses, and they certainly won't catch all three at the
same time; and if they do catch any of the illnesses, the evidence suggests
that their immunity to further attacks will be far greater than is provided by
any vaccine.
Furthermore,
there is some evidence that catching measles actually protects children against
some conditions, such as allergies. A recent trial in Guinea-Bissau found that
25.8% of participants who had the measles vaccine suffered from allergies, as
opposed to 12.8% who had the wild measles.[12]
In the
Immunisation Awareness Newsletter of December 1991, other advantages of
catching measles are considered, as this passage shows:
"The advent of complications
during these diseases essentially depends on the age and the health of the
child, as well as on treatment. We have
lost the common sense and the wisdom that used to prevail in the approach to
childhood diseases. Too often, instead
of reinforcing the organism's defences, fever and symptoms are relentlessly
suppressed. This is not always without
consequences over the development of the disease. On the other hand, given the depth to which the child's organism
is affected by the disease measles, for example, there can also be positive
consequences. For the child's organism
to defeat a disease by its own means, enables it to mature its immune system
and develop increased resistance. The
latter will be useful for the organism against other diseases during childhood,
and likewise in adulthood. Over many
generations, parents, doctors, and educators have noted that children may go
through an important stage of their development thanks to a childhood disease. Conditions in which heredity is a factor,
such as eczema, asthma, or recurring infections of the respiratory system, may
be improved or even cured after measles.”
"This 'cure potential' of
childhood diseases can be demonstrated by an example. There is a serious childhood disease affecting the kidneys, the
nephrotic syndrome, in which the kidneys lose their vital excretion function as
a result of disturbed immunological processes.
Up until the 1960s, at the Bale University Paediatrics Clinic, artificial
infection with the measles was used to treat this syndrome; this brought about
at least an improvement in most cases."[13]
The process of vaccination involves submission to a medical procedure for the benefit of a community; not just for oneself or one's immediate family. Therefore, for a vaccination to be justified, there must be:
_ a serious threat from the
disease(s), and
_ a significant benefit from the
vaccine.
If the
diseases are not as serious as they are now claimed to be (and we have found no indication that any of them has become more
serious in the past 15-20 years quite the reverse)[14];
and if the vaccines are more dangerous than they are admitted to be, then the
risk/benefit ratio is altered. At the very least, parents should know about it.
Behind the
scenes, it is acknowledged that vaccines are indeed not as safe as they could
be:
"The goals of immunization are to
eradicate infectious diseases while minimizing morbidity caused by the vaccine,
particularly to prevent neurological damage. The object of the study is to
evaluate neurological complications associated with the immunization.
Immunization is an important public health measure. Acute reactions warrant
support for development of improved vaccines."[15]
There is always room for improvement in any product, but these
references to "neurological damage" and "Acute reactions"
indicate that in the minds of some there is need for considerable improvement.
The vaccines
MMR Vaccines
The MMR
vaccines were introduced in October 1988, as part of a campaign to reduce
childhood illness. They are a triple vaccine, using the mumps, measles and
rubella live viruses.
Until September 14 1992 there were three types of MMR vaccine available:
|
Vaccine |
Details |
|
IMMRAVAX |
Manufactured
by Merieux UK Ltd |
|
PLUSERIX-MMR |
Manufactured
by SmithKline Beecham/ Smith Kline French Laboratories |
|
MMRII |
Manufactured
by Merck Sharpe and Dohme; distributed by Wellcome (On recent data sheets
this product is now shown as being distributed by Pasteur Merieux MSD Ltd) |
Pluserix-MMR
and Immravax vaccines contain the Urabe strain of mumps vaccine virus; MMRII
vaccine contains the Jeryl Lynn strain of mumps vaccine virus.
On 14
September 1992 the Chief Medical Officer announced that there were to be
"Changes in the supply of vaccine". From that date onwards, only
MMRII would be available. The following is an extract from his letter giving
the reasons for withdrawal:
"This change in vaccine supply arrangements has been
considered prudent following reports of generally mild transient meningitis
caused by the mumps vaccine virus in some children who recently received the
Urabe mumps vaccine containing products, Pluserix-MMR or Immravax. The rate of
post-immunisation meningitis following Jeryl Lynn mumps vaccine (which MMRII
contains) is much lower.
Incidence of
mumps virus meningitis:
"Meningitis after natural mumps has been reported to occur at a rate of approximately 1 per 400 cases.”
"Studies
recently undertaken in one Public Health Laboratory, and supported by similar
studies in several other Public Health Laboratories, suggest that the incidence
of virus positive post-immunisation meningitis from the Urabe strain of mumps
vaccine virus may be approximately 1 in 11,000[16]
immunised children. This rate of vaccine-associated meningitis is appreciable
(sic) lower than that reported after natural mumps infection”
.
"Vaccine-associated
meningitis occurs around three weeks after immunisation generally. In those
instances reported so far it appears to be a milder and more transient illness
than meningitis from wild virus. This is what one might expect with an
attenuated virus. The risk benefit ratio therefore remains strongly in favour
of the immunisation of all children with any MMR vaccine. However the MMRII
vaccine is preferred where this is available because of the much lower risk of
vaccine associated meningitis."[17]
Even though
the Chief Medical Officer mentioned only "changes in supply", both
Immravax and Pluserix have subsequently been withdrawn altogether.[18]
We are
troubled that there seems to be a certain amount of massaging of the figures.
In the passage just quoted, side effects of one in 11,000 are mentioned. Later,
it will be seen that they were brought down to 1/4000[19].
But even that is not the end of the story as this extract from a Japanese study
about the safety of MMR vaccines (with the Urabe mumps strain) will show:
"During the 8‑month period
extending from April to October, 1989, in Gunma Prefecture, 11 750 children
received MMR vaccination according to information supplied by the prefectural
public health center. The incidence of
MMR meningitis was estimated to be 1.1/1000 (0.11%) in the virus‑positive
group and 3/1000 (0.30%) in the three groups.
2640 and 1320 children received MMR vaccination in September and
October, respectively. Twelve children
in the virus‑positive group, 10 in the serum‑positive group and 6
in the clinical group received vaccination in these 2 months. The incidence of virus‑positive, serum‑positive
and clinical meningitis in these 2 months was 3/1000 (0.3%), 2.5/1000 (0.25%),
and 1.5/1000 (0.15%), respectively (total, 7.1/1000 (0.71%))."[20]
We have a
letter from the Japanese Department of Viral Disease and Vaccine Control which
indicates that from April 1993 the use of the MMR vaccine (all types) was
stopped in Japan and that vaccines would be available only in their monovalent
form (i.e. single virus)[21]
Comment:
The Japanese findings indicate that
adverse reactions to these types of MMR
vaccine were up to 78 times as frequent as our Government's Chief Medical
Officer of Health has admitted[22].
If those figures are correct, then the vaccine is more dangerous than the
illness; and it does not give a great deal of confidence that the Government
has got its figures (or information about safety or side effects) right. Note
also that this article was published in March 1991. Yet the two brands of
MMR implicated with these side effects were not withdrawn until September 1992,
some 18 months later.
Indeed TRIVIRIX (a MMR vaccine containing
the Urabe strain virus) was withdrawn in Canada in May 1990.[23]
Why did the UK Government take till 1992 to withdraw it?
The arrival on the scene of the MR Vaccine
In the autumn
of 1994 it was announced that the Government feared an epidemic of measles and
that it aimed to vaccinate all children between the ages of 5 and 16 with the
Measles/Rubella vaccine.
Not everyone
agrees that an epidemic was imminent or that such a widespread vaccination
campaign was necessary.[24]
The story goes back further than that - to the MMR vaccines.
The two brands
of MR Vaccine which were used in the schools campaign are produced by the same
manufacturers as were the two brands of MMR vaccine which have now been
withdrawn (see above):
Merieux UK Ltd (Measles Rubella Vaccine Live Pasteur)
and SmithKline Beecham (Eolarix)
As far as we
can tell the active constituents of these two vaccines are exactly the same as
those in their withdrawn MMR vaccines, except that the mumps component has been
removed. Both brands of MR vaccines
each contain 2 viruses - to provide protection against Measles and Rubella.
A new MMR vaccine
In 1997 a new
version of MMR was introduced - Priorix
manufactured by Smithkline Beecham. We have no information at present about the
performance or safety of this vaccine.
Safety of the vaccines.
We deal below with side effects, but we are disturbed at the lack of evidence of long-term safety trials. At the risk of repetition we set out again the extract from the publication referred to in our vaccines general information fact sheet:
"In the course of its review, the
committee encountered many gaps and limitations in knowledge bearing directly
and indirectly on the safety of vaccines.
These include inadequate understanding of the biologic mechanisms
underlying adverse events following natural infection or immunization,
insufficient or inconsistent information from case reports and case series,
inadequate size or length of follow-up of many population-based epidemiological
studies, and limited capacity of existing surveillance systems of vaccine
injury to provide persuasive evidence of causation. The committee found few experimental studies published in
relation to the number of epidemiological studies published. Clearly, if research capacity and
accomplishment in these areas are not improved, future reviews of vaccine
safety will be similarly handicapped."[25]
So far, most
of the safety trials which we have identified, have monitored the children for
just 3 weeks after the vaccine was administered; and the longest we have so far
been able to find is a monitoring period of six weeks. It means that any adverse effect which occurred after the monitoring
period would not have been observed. The safety trials, in the main, have been of the separate
components of the vaccines (i.e. Mumps, Measles and Rubella). Trials of the
combined vaccine appear to be even thinner on the ground. This is admitted by
the Committee on Safety of Medicines:
"Before
measles, mumps, rubella (MMR) vaccine was introduced in this country, we
carried out a large scale study where adverse events were monitored in the
three week period following vaccination in approximately 12,000 children."[26]
This is
troubling because there special considerations should be given when more than
one live virus is administered as a vaccine at the same time. There is evidence
that the measles virus (or vaccine) can cause immunosuppression[27],
which in turn might allow opportunistic infection to develop from one of the
other viruses (such as rubella). Other
concerns have also been expressed:
"Modern
vaccine programs seem to ignore the high potential for mutation of viruses. It
was established in 1986 that a mixture of non-virulent viruses can produce a
disease by means of complementation or recombination. A team from the
University of California (Los Angeles) inoculated mice with two strains of
non-virulent herpes simplex virus type 1. Most of those that received a 1:1
mixture of viruses died. But the animals which received a 100 fold higher dose
of only one strain of virus survived. Virulent recombination’s had been
produced. As early as 1984 R de Long warned that mass immunization with several
live viral vaccines might increase the probability of genetic recombination and
might result in new diseases."[28]
If anyone can help us to identify longer-lasting safety trials we
would be grateful to receive details.
We have asked the
Committee on Safety of Medicines to supply us with details of long term safety
monitoring of vaccines and they have so far been unable to supply them.
Side effects:
the official view
There is a
concept in medical cases called "informed consent". In simple terms,
has a patient been given adequate information to be able to make an informed decision about whether or not
to have a particular type of treatment?
Because a child does not need to be vaccinated there must be a
duty to give very comprehensive information, so that parents can decide. Even
chances of several thousand to one against side effects may be unacceptable,
particularly as a child is put at risk of side effects as soon as a vaccine is
administered.
Yet little
information is made available about the side effects of the vaccines. They are
always played down, and in the booklets encouraging parents to have their
children vaccinated; they are hardly mentioned at all. In the booklet given to
families at the time of the Measles Rubella campaign in 1994 the following is
the entire information relating to safety of the vaccines:
Will
my child have any side effects after the injection
“Side effects
are uncommon. They are usually very mild and disappear quickly. A few children
may get a mild fever, a rash, sore or aching joints, or feel a bit 'off-colour'
a week to ten days after the jab. But this should only last two or three days.
Children with these symptoms cannot give anyone measles or rubella.”[29]
No other information giving details of side effects is contained in any part of the booklet.
As can be seen, side effects do certainly exist:
"Reactions
from the live [measles] vaccine are usually mild, although convulsions and rare
cases of encephalopathy[30]
have occurred in connection with vaccination campaigns, but with the
improvement in vaccine production reactions are becoming less common. The risk
is certainly acceptable in countries where measles is still a killing
disease."[31]
We realise that this passage was written in 1979, but by then measles vaccine had been widely used in this country for more than 10 years. It is rather odd, therefore, that the author is talking about an "acceptable risk" in countries where measles is still a killer disease. The same argument can be applied (justifiably) about vaccinations against AIDS, where the risks from the illness are very severe. But deaths from measles in this country have remained low since the 1950s.
The following
is the list of side effects taken from the datasheet for one of the brands of
MMR vaccine (MMRII). It should be emphasised that this too plays down the
incidence of vaccine side effects, but it does give much more information than
is generally available to the public:
From the MMR datasheet
"Because the vaccine is slightly acidic (pH 6.2‑6.6),
patients may complain or burning and/or stinging at the injection site for a
short time."Adverse reactions associated with MMRII are similar to those
to be expected from administration of monovalent vaccines given separately.
These may include malaise, sore throat, headache, fever and rash, nausea and
vomiting; mild local reactions such as erythema, induration, tenderness and
regional lymphadenopathy; parotitis, orchitis, nerve deafness, thrombocytopenia
and purpura; allergic reactions such as wheal and flare at the injection site
or urticaria; polyneuritis; and arthralgia and/or arthritis (usually transient
and rarely chronic). Cough, coryza and pharyngitis have also occurred.”
"Moderate fever (38.3'C/101'F) or high fever (above 39.4'C/103'F) may occur following vaccination, predominantly between days 5 and 10. On rare occasions, children developing fev